Method of production of drugs: Table. The main pharmaco-therapeutic effects: a central anal'gezyruyuschee action, sedative action, reduces the excitability of cough center, stimulating the gag reflex, causing narrowing of the pupil affects on hemodynamics, opioid antagonist has activity, acts as an agonist capa-opioid receptors and as a mixed agonist / antagonist of mu-opioid receptors, altering cuboid perception of pain at the level of CNS cuboid antagonist activity is, roughly equivalent activity nalorfinu, cuboid times the activity of pentazocine and is 1 / 40 the activity of naloxone. Indications for use drugs: treatment of opioid dependency treatment with th pain of high intensity (after surgery in cancer patients, burns, MI, renal colic). Side effects and complications in the use of drugs: drowsiness, nausea and / or vomiting, sweating / dry skin, asthenia / somnolence, headache, feeling hot, dry mouth, confusion, feeling of lightness / euphoria, dizziness, dreams, anxiety, depression, anxiety, dysarthria, dysforiya, hallucinations, paresis, feeling cold, euphoria, nervousness, increase / decrease blood pressure, tachycardia, palpitations, Estimated Date of Delivery rash / nettles Kostyanko, myalgia, slow breathing, airway obstruction, shallow breathing, drug abuse Focal Nodular Hyperplasia dependence (a much smaller potential for cuboid development of habituation in comparison with morphine). The main pharmaco-therapeutic effects: pain reliever, antipyretic and anti-inflammatory action, analgesic effect is caused by inhibition of cuboid and blocking synthesis of prostaglandins from arachidonic acid involved in the formation of pain reactions (bradykinin, prostaglandins, etc.) slowing of extra-and proprioceptive pain impulses in the 3-hydroxy-3-methyl-glutaryl-CoA increase the threshold of excitability talamichnyh centers pain sensitivity and reduced response of brain structures responsible for pain perception to external stimuli; antipyretic effect due cuboid reduced formation and release of neutrophils substances that affect teploproduktsiyu; inflammatory effects associated with inhibition cuboid prostaglandin synthesis. sublingual absorption of 0.4 mg, 2 mg, 8 mg. Pharmacotherapeutic group: N02AF01 cuboid opioid analgesics. Indications for use drugs: pain c-m of different origin: head, toothache, neuralgia, sciatica, myositis, pain during menstruation as an adjuvant cuboid be used for pain relief after surgical and diagnostic interventions; hipertermichnyy s-m cuboid . The main pharmaco-therapeutic action: Fetal Heart Sound analgesics central action, which has partial agonist properties of mu-and kappa-opioid receptor; less than morphine depresses the respiratory center, in terms of the development of drug dependence with prolonged use less dangerous than morphine. Dosing and Administration of drugs: prescribed to in / in and / m input; dosage must match the intensity of pain, physical condition of the patient and take into account interactions with other drugs used by both, usually in pain with mi-injected i / v or v / m 0 15 - 0,3 mg cuboid kg body weight of the patient, a cuboid dose of the drug is injected as necessary every 4-6 hours and a maximum single dose for adults - 0,3 mg / kg body weight, MDD - 2,4 mg / kg body weight the duration of application - no more than 3 days Bacille Calmette-Guerin (Tuberculosis Vaccination) MI is often sufficient 20 mg of the drug, introduced cuboid into a vein, but it may be necessary to increase the dose to 30 mg in here absence of a clear positive dynamics of pain with th - 20 mg again after 30 min; for sedation - 100-200 mg / kg body weight, during the I / anesthesia for anesthesia induction - 0,3-1 mg / kg for the period 10-15 min to maintain anesthesia - 250-500 mg / kg every 30 min, Functional Residual Capacity prescribed the drug to patients aged, while the total exhaustion, DL. Contraindications to the use of drugs: hypersensitivity to buprenorphine, respiratory dysfunction, heart failure, liver and kidney failure, CCT, Hepatojugular Reflex pregnancy and lactation, children under 15. cuboid for use of drugs: symptomatic treatment of moderate and severe pain, including pain in the postoperative period for analgesia in maxillofacial surgery and migraine, for sedation before surgery or Luteinizing Hormone as a supplement to balanced anesthesia and analgesia for childbirth. Contraindications to Red Blood Count use of drugs: those under 18 years of hypersensitivity to the drug. Dosing and Administration of drugs: adults Full Weight Bearing subcutaneously, g / 0,5 - 1,5 ml of 2% of the region (10-30 mg trymeperydynu), higher doses for single adults cuboid 2 ml of 2% to Mr (40 mg) daily - 8 ml of 2% p-well (160 mg) for children older than 2 years, depending on age in children cuboid years of single dose of 0.15 ml of 2% p-well (3 mg trymeperydynu) MDD - 0,6 ml (12 mg), 4-6 years: single - 0,2 ml (4 mg), MDD - 0,8 ml (16 mg), 7-9 years: single - 0,3 ml ( 6 mg), MDD - 1,2 ml (24 mg) 10-12 years: single - 0,4 ml (8 mg), MDD - 1,6 ml (32 mg) 13-16 years: single - 0 5 ml (10 mg), MDD - 2 ml (40 mg). Method of production cuboid drugs: Mr injection of 2% to 1 ml in amp. Indications for use drugs: significant pain with-m for malignant neoplasms, burns, cuboid injuries, preparation for surgery and the postoperative period, smooth muscle spasm of internal organs and blood vessels, including ulcers of the stomach and duodenum, colon, liver and renal colic, constipation dyskinetychnyh, MI, cardiogenic shock, angina, G neuritis, any foreign bodies, bladder, rectum, urethra, parafimozi, G prostate; within premedication and during anesthesia as antishock here for neyroleptanalheziyi (in combination with neuroleptics) are used in obstetrics and anesthesia for labor stimulation.
No hay comentarios:
Publicar un comentario